Issue 10, 2016
From the journal:

MedChemComm

Potentiation of the fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida†‡

Matthew D. Stephens,a   Nisakorn Yodsanitb  and  Christian Melander*a  

* Corresponding authors

a Department of Chemistry, North Carolina State University, 2620 Yarbrough Drive, Raleigh, NC 27695, USA
E-mail: ccmeland@ncsu.edu

b Department of Chemistry, Mahidol University, 999 Phuttamonthon 4 Road, Salaya 73170, Thailand

Abstract

A library of 33 compounds was screened for potentiation of the antibiotic FR 900098 against the Francisella tularensis surrogate Francisella novicida. From the screen a highly potent 2-oxazoline adjuvant was discovered capable of potentiating FR 900098 with a 1000-fold reduction in MIC against the Francisella sub-species F. novicida and F. philomiragia.

Graphical abstract: Potentiation of the fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C6MD00365F
Article type
Research Article
Submitted
30 Jun 2016
Accepted
26 Jul 2016
First published
27 Jul 2016

Med. Chem. Commun., 2016,7, 1952-1956

Permissions

Request permissions

Potentiation of the fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida

M. D. Stephens, N. Yodsanit and C. Melander, Med. Chem. Commun., 2016, 7, 1952 DOI: 10.1039/C6MD00365F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements